Patent · US Active

Use of spiegelmers to inhibit an intracellular target molecule

US8497250B2 · kind B2 · utility

2Cited by
2References
28Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 4, 2006
Grant dateJul 30, 2013
Priority date
Expiry dateAug 6, 2027

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2500/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to the use of a L-nucleic acid as intracellularly active agent.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.